{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Duborimycin",
  "nciThesaurus": {
    "casRegistry": "28008-55-1",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "An anthracycline antineoplastic antibiotic with therapeutic effects similar to those of doxorubicin.  Duborimycin exhibits cytotoxic activity through topoisomerase-mediated interaction with DNA, thereby inhibiting DNA replication and repair and RNA and protein synthesis.",
    "fdaUniiCode": "YDU8YIP30L",
    "identifier": "C1062",
    "preferredName": "Duborimycin",
    "semanticType": "Antibiotic",
    "subclassOf": [
      "C1594"
    ],
    "synonyms": [
      "13-Hydroxydaunomycin",
      "5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8, 9,10-tetrahydro-6,8,11-trihydroxy-8-(1-hydroxyethyl)-1-methoxy-, (8S-cis)-, hydrochloride",
      "DAUNORUBICINOL",
      "Daunomycinol",
      "Daunomycinol HCl",
      "Daunorubicineal",
      "Daunorubicinol",
      "Duborimycin",
      "Duborimycin Hydrochloride",
      "Duborimycine",
      "Duborimycine, Hydrochloride"
    ]
  }
}